Harnessing Inorganic Nanomaterials for Chemodynamic Cancer Therapy
Nanomedicine · 2022
DOI: 10.2217/nnm-2022-0187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomedicine, 2022. Verfasst von Dhelal F Mohammed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq. Hauptthemen laut MEDLINE: Neoplasms, Nanostructures, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
The most important aspect of chemodynamic therapy (CDT) is the harnessing of Fenton or Fenton-like chemistry for cancer therapy within the tumor microenvironment, which occurs because of the moderate acidity and overexpressed H2O2 in the tumor microenvironment. Hydroxyl radicals (•OH) produced within tumor cells via Fenton and Fenton-like reactions cause cancer cell death. Reactive oxygen species-mediated CDT demonstrates a desired anticancer impact without the need for external stimulation or the development of drug resistance. Cancer therapy based on CDT is known as a viable cancer therapy modality. This review discusses the most recent CDT advancements and provides some typical instances. As a result, potential methods for further improving CDT efficiency under the guidance of Fenton chemistry are offered. Cancer is one of the leading causes of death worldwide. Unfortunately, conventional treatments do not greatly increase the quality of life or survival rate of cancer patients. So, coming up with new, less invasive ways to treat cancer would be an important way to increase the number of cancer patients who survive. Chemodynamic therapy, a new cancer treatment modality, uses intracellular hydrogen peroxide as a fantastic ‘Trojan horse’ to produce highly toxic hydroxyl radicals (•OH) to kill cancer cells. This review discusses the most recent advancements in chemodynamic therapy and provides some typical instances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
- Radiological Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
- Department of Dentistry, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
- Anesthesia Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
- Department of Business Administration, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
- Department of Medical Physics, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq.
Zitieren
APA
Mohammed, D. F., Madlool, H. A., Faris, M., Shalan, B. H., Hasan, H. H., Azeez, N. F., & Abbas, F. H. (2022). Harnessing Inorganic Nanomaterials for Chemodynamic Cancer Therapy. Nanomedicine. https://doi.org/10.2217/nnm-2022-0187
Vancouver
Mohammed DF, Madlool HA, Faris M, Shalan BH, Hasan HH, Azeez NF, et al. Harnessing Inorganic Nanomaterials for Chemodynamic Cancer Therapy. Nanomedicine. 2022. doi:10.2217/nnm-2022-0187
BibTeX
@article{Mohammed2022,
author = {Mohammed, Dhelal F and Madlool, Hussein A and Faris, Mohammed and Shalan, Bashar Hadi and Hasan, Huda Hadi and Azeez, Nidaa F and Abbas, Fatima Hashim},
title = {Harnessing Inorganic Nanomaterials for Chemodynamic Cancer Therapy},
journal = {Nanomedicine},
year = {2022},
doi = {10.2217/nnm-2022-0187}
}
EUVIMED